Meeting Impression | Latest frontiers in anticoagulation therapy
See below to download the Meeting Impression
In this live webcast, prof. John Eikelboom summarized recent clinical evidence on non-vitamin K antagonist anticoagulants / direct oral anticoagulants (NOACs or DOACs) in patients with both atrial fibrillation (AF) and venous thromboembolism (VTE). The webcast was moderated by prof. Saskia Middeldorp and dr. Hanna Pohjantähti-Maaroos. The panel discussed clinical guidance based on these novel insights and provided an expert perspective on how to use these agents in the most optimal way.
The educational objectives of this webcast were:
- To review and summarize recent clinical evidence on non-vitamin K antagonist anticoagulants (NOACS) in patients with atrial fibrillation and thrombosis
- To provide clinical guidance, based on novel insights on safety and tolerability, on management of patients in challenging situations
- To provide an expert perspective on the appropriate use of NOACs in clinical practice
Prof. John Eikelboom - McMaster University, Hamilton, Ontario, Canada
Prof. Saskia Middeldorp - Academic Medical Center, Amsterdam, The Netherlands
Dr. Hanna Pohjantähti-Maaroos - Kuopio University Hospital, Finland
The live webcast was organised by the PACE Foundation and supported by an unrestricted educational grant from Boehringer Ingelheim.